Poster Presenter: Francesco Ferro, MD, Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Italy
Ignite Session 2B
Saturday, November 12 | 2:40–2:45 p.m. ET | Center City Stage
All ACR Convergence 2022 poster presentations are available on demand to registered meeting participants through October 31, 2023.
What is your poster about?
This poster is about the impact of a rheumatological approach, based on combination treatment with pulse steroid and baricitinib, on mortality and inflammatory response in severe COVID-19 patients requiring intensive care unit support.
Why did you decide to investigate this topic?
Since the beginning of the COVID-19 pandemic, I was directly involved in designing immunomodulatory treatment protocols for severe COVID-19 patients. Our group has noticed strong similarities between severe hyperinflammatory COVID-19 pneumonia and some rapidly progressive interstitial lung disease secondary to systemic autoimmune diseases.
What are you working on next related to this research?
I established a strong multidisciplinary network with the anesthesiologists of our geographical area in order to improve the outcome of patients with severe COVID-19 as well as of patients with the most severe type of rheumatic diseases.
What excites you most about your work?
This has been a great chance to apply the “rheumatological” thinking approach to the intensive care setting, with a remarkable gain in terms of knowledge growth and, most importantly, of lives saved.